Market Research Logo

Interface Biologics Inc - Product Pipeline Analysis, 2018 Update

Summary

Interface Biologics Inc (IBI) is a medical device company that develops transformative biomedical polymer technologies. The company offers anti-thrombogenic and combination drug delivery devices. Its anti-thrombogenic additives reduce thrombosis in blood contacting medical devices and polymer enabled drug delivery platforms. IBI’s technologies include endexo, kinesyx and epidel. The company provides combination drug delivery devices which include Epidel and Kinesyx. Its products improve the safety and effectiveness of implantable medical devices. The company serves dialysis patients in Canada and abroad. IBI is headquartered in Toronto, Ontario, Canada.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Interface Biologics Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Interface Biologics Inc Company Overview
Interface Biologics Inc Company Snapshot
Interface Biologics Inc Pipeline Products and Ongoing Clinical Trials Overview
Interface Biologics Inc – Pipeline Analysis Overview
Interface Biologics Inc - Key Facts
Interface Biologics Inc - Major Products and Services
Interface Biologics Inc Pipeline Products by Development Stage
Interface Biologics Inc Pipeline Products Overview
EPICUFF
EPICUFF Product Overview
EPISCREW - Dental Implant
EPISCREW - Dental Implant Product Overview
EPISCREW - Orthopedic Fixation Device
EPISCREW - Orthopedic Fixation Device Product Overview
Interface Biologics Inc - Key Competitors
Interface Biologics Inc - Key Employees
Interface Biologics Inc - Locations And Subsidiaries
Head Office
Recent Developments
Interface Biologics Inc, Recent Developments
Feb 14, 2011: Interface Biologics Appoints Art Rosenthal To Chairman Of Board Of Directors
Oct 26, 2010: Interface Biologics Receives ISO 13485:2003 Certification
Dec 09, 2008: Interface Appoints President And Board Member
Aug 25, 2007: Interface Appoints New Advisory Board Member
May 08, 2007: Interface Appoints New Advisory Board Member
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Interface Biologics Inc Pipeline Products and Ongoing Clinical Trials Overview
Interface Biologics Inc Pipeline Products by Equipment Type
Interface Biologics Inc Pipeline Products by Indication
Interface Biologics Inc, Key Facts
Interface Biologics Inc, Major Products and Services
Interface Biologics Inc Number of Pipeline Products by Development Stage
Interface Biologics Inc Pipeline Products Summary by Development Stage
EPICUFF - Product Status
EPICUFF - Product Description
EPISCREW - Dental Implant - Product Status
EPISCREW - Dental Implant - Product Description
EPISCREW - Orthopedic Fixation Device - Product Status
EPISCREW - Orthopedic Fixation Device - Product Description
Interface Biologics Inc, Key Employees
Glossary
List of Figures
Interface Biologics Inc Pipeline Products by Equipment Type
Interface Biologics Inc Pipeline Products by Development Stage

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report